Last quarter (Q3 2022), Epigenomics's total revenue was €145.00K, a decrease of -97.50% from the same quarter last year. In Q3, Epigenomics's net income was €-1.56M. See Epigenomics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	€ 567.00K	€ 6.20M	€ 842.00K	€ 1.13M	€ 1.53M	€ 1.86M
Cost of Revenue	€ 137.00K	€ 136.00K	€ 145.00K	€ 254.00K	€ 467.00K	€ 227.00K
Gross Profit	€ 430.00K	€ 6.07M	€ 697.00K	€ 871.00K	€ 1.07M	€ 1.64M
Operating Expense	€ 12.39M	€ 10.23M	€ 10.81M	€ 15.97M	€ 14.36M	€ 11.49M
Operating Income	€ -11.96M	€ -4.16M	€ -10.11M	€ -15.10M	€ -13.29M	€ -9.86M
Net Non Operating Interest Income Expense	€ -44.00K	€ -56.00K	€ -36.00K	€ 107.00K	€ -535.00K	€ -160.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	€ -7.25M	€ -2.41M	€ -11.66M	€ -14.57M	€ -13.43M	€ -10.45M
Tax Provision	€ 7.00K	€ 18.00K	€ 23.00K	€ 2.45M	€ -738.00K	€ -214.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	€ -7.25M	€ -2.43M	€ -11.69M	€ -17.02M	€ -12.69M	€ -10.23M
Basic EPS	€ -0.15	€ -0.22	€ -1.82	€ -3.32	€ -3.69	€ -3.13
Diluted EPS	€ -0.15	€ -0.22	€ -1.82	€ -3.32	€ -3.69	€ -3.13
Basic Average Shares	€ 15.54M	€ 11.21M	€ 6.40M	€ 5.16M	€ 3.44M	€ 3.25M
Diluted Average Shares	€ 15.54M	€ 11.21M	€ 6.40M	€ 5.16M	€ 3.44M	€ 3.25M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	€ 12.53M	€ 10.37M	€ 10.96M	€ 16.23M	€ 14.82M	€ 11.72M
Net Income From Continuing And Discontinued Operation	€ -7.25M	€ -2.43M	€ -11.69M	€ -17.02M	€ -12.69M	€ -10.23M
Normalized Income	€ -7.25M	€ -2.42M	€ -11.69M	€ -17.02M	€ -12.69M	€ -10.39M
Interest Expense	€ 85.00K	€ 52.00K	€ 55.00K	€ 63.00K	€ 550.00K	€ 175.00K
EBIT	€ -7.16M	€ -2.36M	€ -11.61M	€ -14.50M	€ -12.88M	€ -10.27M
EBITDA	€ -6.51M	€ -1.94M	€ -11.07M	€ -13.99M	€ -12.57M	€ -9.93M

Currency in EUR

Epigenomics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing